Bio-Connect

Anti-CD146 [ABX-MA1 (3.19.1)]

Research Use Only
AB02820-11.0-BT
Absolute Antibody
ApplicationsFunctional Assay, Flow Cytometry, Western Blot, ELISA
Product group Antibodies
ReactivityHuman
TargetMCAM
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Absolute Antibody
  • Product Name
    Anti-CD146 [ABX-MA1 (3.19.1)]
  • Delivery Days Customer
    9
  • Antibody Specificity
    This antibody binds human CD146 (MCAM/MUC18). CD146 is a cell-surface glycoprotein composed of a signal peptide, five immunoglobulin-like domains, a transmembrane region, and a short cytoplasmic tail . Its expression is associated with tumor progression a
  • Application Supplier Note
    A number of studies have identified MUC18 as a marker of tumor progression and metastasis in melanomas (PMID: 2602381; 3542195; 8162602). The binding specificity of the human IgG2 version of this antibody for human CD146 was checked using ELISA. The original human IgG2 version of this antibody was also able to detect MUC18 expressed on melanoma cell lines like A375SM, TXM-13 and WM-2664 in a western blot assay. The human IgG2 version was also able to identify native MUC18 expression on A375-SM and WM-2664 cells in a flow cytometric assay (PMID: 12208768; US6924360). ABX-MA1 had no effect on melanoma cell proliferation rate in vitro. ABX-MA1 treatment of melanoma cells in vitro significantly inhibited the promoter and collagenase activity of matrix metalloproteinase 2, resulting in decreased invasion through Matrigel-coated filters. ABX-MA1 inhibited tumor growth in nude mice injected with metastatic melanoma lines A375SM and WM2664. ABX-MA1 also disrupted spheroid formation by melanoma cells expressing MUC18 (homotypic interaction) and the ability of these cells to attach to human vascular endothelial cells [HUVECs (MUC18 positive)] in vitro. ABX-MA1 treatment also suppressed experimental lung metastasis of these melanoma cells (PMID: 12208768). This antibody was also used in an in vitro and in vivo study of role of MUC18 in the metastasis of osteosarcoma (PMID: 14695161). A combination of ABX-MA1 and anti-IL-8 (ABX-IL8) was studied as model combinations for the treatment of melanoma (PMID: 16965268).
  • Applications
    Functional Assay, Flow Cytometry, Western Blot, ELISA
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    ABX-MA1 (3.19.1)
  • Gene ID4162
  • Target name
    MCAM
  • Target description
    melanoma cell adhesion molecule
  • Target synonyms
    CD146; cell surface glycoprotein MUC18; cell surface glycoprotein P1H12; Gicerin; HEMCAM; melanoma adhesion molecule; melanoma-associated antigen A32; melanoma-associated antigen MUC18; MelCAM; METCAM; MUC18; S-endo 1 endothelial-associated antigen
  • Host
    Human
  • Isotype
    IgG2
  • Protein IDP43121
  • Protein Name
    Cell surface glycoprotein MUC18
  • Reactivity
    Human
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    12352203